605507.SS
605507.SS
CNE100004NS2
GUOBANG PHARMA LTD
Loading chart...

Valuation & History

Quarterly trend of key valuation metrics

Metric
Current (TTM) TTM Baseline
Q2 '26 30.06.2026
Q1 '26 31.03.2026
Q4 '25 31.12.2025
Market & Enterprise Value
Market Cap
13.54B EUR
11.58B EUR
14.52B EUR
13.86B EUR
Enterprise Value
11.88B EUR
11.16B EUR
14.01B EUR
13.39B EUR
Valuation Multiples
Trailing P/E
19.02x
23.54x
26.32x
22.86x
Forward P/E
--
--
--
--
Price to Sales
2.21x
2.47x
3.12x
3.03x
Price to Book
1.59x
1.38x
1.67x
1.62x
EV/Revenue
1.94x
2.38x
3.01x
2.93x
EV/EBITDA
9.11x
18.94x
20.57x
18.36x
Price to FCF (P/FCF)
26.28x
42.81x
24.87x
154.82x
EV/FCF
23.05x
41.27x
23.98x
149.58x
FCF Yield
3.81%
2.34%
4.02%
0.65%
ende